Company intelligence / Profile preview

Epica International

Landrum, South Carolina, United States

Ownership: Private
Development stage: Other

Overview

Epica International's advanced medical imaging platforms (such as SeeFactor CT3, Vimago GT30, and Pegaso Evolution) are FDA 510(k) cleared for human use and are commercially deployed in human and veterinary healthcare for diagnostic and intraoperative imaging. The company is recognized for ultra-high resolution, mobile, multi-modality imaging platforms but does not develop therapeutics or engage in clinical trials.

Modalities: Device
Industry: Medical Imaging

Partnerships

Esaote North AmericaCatalyst MedTech

Beyond the preview

Go deeper on Epica International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epica International.

Explore the full profile